Sign in with Google. Opens in new tab
bullish
CStone Pharma (基石药业) IPO: Strong Assembly and Backing (Part 1)
975 Views25 Jan 2019 06:51
CStone Pharma is raising up to USD 400 million via a listing on the Hong Kong Stock Exchange. In this insight, we will discuss the following...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »Top Unpaywalled Insights
More »- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
- HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- HLX02: Innovation Could Overtake18 Feb 2019
- CStone Pharma (基石药业) IPO: Thoughts on Valuation (Part 2)11 Feb 2019
- Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio30 Jan 2019
- CStone Pharma (基石药业) IPO: Strong Assembly and Backing (Part 1)25 Jan 2019
- Innovent Biologics IPO Valuation: Surprisingly Grounded in Reality15 Oct 2018
- Innovent Biologics IPO Preview: Limited Upside on China's PD-1 Drug Market Compared to BeiGene01 Oct 2018
x